SCHEMBL6898815

SCHEMBL6898815

CC/C=C\CCCCCC(=O)OCC(C)C

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.67
CYP3A4 P08684 2/20 0.67
ALOX15 P16050 2/20 0.67
HSD17B10 Q99714 2/20 0.67
TDP1 Q9NUW8 2/20 0.67
TSHR P16473 1/20 0.67
DGKA P23743 1/20 0.60
PRKCE Q02156 1/20 0.57
PRKCQ Q04759 1/20 0.57
PRKCD Q05655 1/20 0.57
PRKCA P17252 1/20 0.57
NR1I2 O75469 2/20 0.57
PTGS2 P35354 2/20 0.57
PGR P06401 1/20 0.57
ADORA3 P0DMS8 1/20 0.57
PDE4D Q08499 1/20 0.57
LPAR1 Q92633 6/20 0.53
ENPP2 Q13822 3/20 0.53
LPAR4 Q99677 2/20 0.53
LPAR5 Q9H1C0 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12116643 1.00 ALDH1A1 (0.67) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL12437840 1.00 ALDH1A1 (0.67) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL1413230 0.95 ALDH1A1 (0.75) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL6895644 0.93 ADORA3 (0.65) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL18095569 0.90 MAPT (0.66) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL17024457 0.90 MAPT (0.66) ALDH1A1CYP3A4ALOX15HSD17B10TDP1
SCHEMBL2397694 0.90 DGKA (0.68) TDP1DGKAPRKCEPRKCQPRKCD
SCHEMBL332986 0.90 DGKA (0.73) TDP1DGKAPRKCEPRKCQPRKCD
SCHEMBL9169298 0.90 DGKA (0.73) TDP1DGKAPRKCEPRKCQPRKCD
SCHEMBL332985 0.90 DGKA (0.73) TDP1DGKAPRKCEPRKCQPRKCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9670200-B2 Quaternary ammonium salt prodrugs ALKERMES PHARMA IRELAND LIMITED (IE) 2017-06-06 US disclosed
US-20110178068-A1 Quaternary Ammonium Salt Prodrugs ALKERMES, INC. (US) 2011-07-21 US disclosed
US-20110166128-A1 Diaryldiazepine Prodrugs for the Treatment of Neurological and Psychological Disorders ALKERMES, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178068-A1 Quaternary Ammonium Salt Prodrugs SLC1A5, IDH1, ASS1 ALDH1A1 74/4885CYP3A4 978/4885ALOX15 3303/4885
US-20110166128-A1 Diaryldiazepine Prodrugs for the Treatment of Neurological and Psychological Disorders HTR5A, HTR2C, HTR2B ALDH1A1 760/4885CYP3A4 22/4885ALOX15 2718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.